Pharmacokinetics of emtricitabine/tenofovir disoproxil fumarate among transgender adolescents and young adults without HIV receiving gender affirming hormones.
Sign Up to like & getrecommendations! Published in 2022 at "AIDS research and human retroviruses"
DOI: 10.1089/aid.2022.0043
Abstract: The transgender community has expressed concerns regarding drug-drug interactions between HIV-pre-exposure prophylaxis (PrEP) and gender-affirming hormones. In this study, we evaluated emtricitabine (F, FTC)/tenofovir disoporoxil fumarate (TDF) pharmacokinetics among adolescent and young adult transgender persons… read more here.
Keywords: transgender; receiving gender; gender affirming; ftc ... See more keywords
What is the most anticipated change induced by treatment using gender‐affirming hormones in individuals with gender incongruence?
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Urology"
DOI: 10.1111/iju.14499
Abstract: To identify the most eagerly anticipated change resulting from hormone therapy using gender‐affirming hormones for patients with gender incongruence undergoing a clinical trial. read more here.
Keywords: affirming hormones; gender incongruence; gender affirming; using gender ... See more keywords
Abstract 13215: Gender-affirming Hormones Are Associated With Increased Risk of QT Prolongation in Transgender Females
Sign Up to like & getrecommendations! Published in 2020 at "Circulation"
DOI: 10.1161/circ.142.suppl_3.13215
Abstract: Introduction: Women have a longer QT interval than men. This sex-specific difference is attributed to hormones associated with the biological female sex. Male-to-female transgender individuals ofte... read more here.
Keywords: affirming hormones; 13215 gender; transgender; gender affirming ... See more keywords
Initiating gender-affirming hormones for transgender and non-binary people: A qualitative study of providers’ perspectives on requiring mental health evaluations
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0271785
Abstract: Objective Gender-affirming hormones (GAH)—the use of sex hormones to induce desired secondary sex characteristics in transgender individuals—is vital healthcare for many transgender people. Among prescribers of GAH, there is debate regarding the value of a… read more here.
Keywords: evaluation; health; gender affirming; mental health ... See more keywords